1
/
of
1
Elabscience
SKU:PKSV030430
Recombinant SARS-CoV-2 Spike RBD(Q409E)(His Tag)
Recombinant SARS-CoV-2 Spike RBD(Q409E)(His Tag)
Regular price
$1,105.00 USD
Regular price
Sale price
$1,105.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant SARS-CoV-2 Spike RBD(Q409E)(His Tag), a cutting-edge product designed to facilitate advanced research and development in the field of virology. This meticulously engineered recombinant protein offers an invaluable tool for studying the Spike Receptor Binding Domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD(Q409E)(His Tag) showcases a unique mutation at position Q409E, enabling researchers to investigate the functional implications of this specific alteration. The inclusion of a His Tag further enhances the protein's versatility, allowing for efficient purification and subsequent downstream applications.
This product serves as an indispensable resource for elucidating the intricate mechanisms underlying viral entry and host cell interaction. By employing the Recombinant SARS-CoV-2 Spike RBD(Q409E)(His Tag), scientists can delve into the intricate details of viral pathogenesis, receptor recognition, and potential therapeutic interventions.
With its exceptional purity, stability, and reproducibility, this recombinant protein guarantees optimal performance and reliability in a wide range of experimental settings. Its high affinity for the angiotensin-converting enzyme 2 (ACE2) receptor, the primary target of SARS-CoV-2, enables precise investigations into viral-host interactions, viral neutralization assays, and the development of novel antiviral strategies.
The Recombinant SARS-CoV-2 Spike RBD(Q409E)(His Tag) is meticulously manufactured in compliance with stringent quality control measures, ensuring the utmost integrity and consistency of each batch. Its exceptional bioactivity and structural fidelity make it an indispensable asset for researchers striving to unravel the complexities of SARS-CoV-2 and combat the ongoing global health crisis.
In summary, the Recombinant SARS-CoV-2 Spike RBD(Q409E)(His Tag) stands as a pinnacle of scientific innovation, offering an unparalleled opportunity to explore the intricate dynamics of viral-host interactions. This product is poised to revolutionize the field of virology, empowering researchers to make significant strides towards understanding, combating, and ultimately eradicating the SARS-CoV-2 virus.
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD(Q409E)(His Tag) showcases a unique mutation at position Q409E, enabling researchers to investigate the functional implications of this specific alteration. The inclusion of a His Tag further enhances the protein's versatility, allowing for efficient purification and subsequent downstream applications.
This product serves as an indispensable resource for elucidating the intricate mechanisms underlying viral entry and host cell interaction. By employing the Recombinant SARS-CoV-2 Spike RBD(Q409E)(His Tag), scientists can delve into the intricate details of viral pathogenesis, receptor recognition, and potential therapeutic interventions.
With its exceptional purity, stability, and reproducibility, this recombinant protein guarantees optimal performance and reliability in a wide range of experimental settings. Its high affinity for the angiotensin-converting enzyme 2 (ACE2) receptor, the primary target of SARS-CoV-2, enables precise investigations into viral-host interactions, viral neutralization assays, and the development of novel antiviral strategies.
The Recombinant SARS-CoV-2 Spike RBD(Q409E)(His Tag) is meticulously manufactured in compliance with stringent quality control measures, ensuring the utmost integrity and consistency of each batch. Its exceptional bioactivity and structural fidelity make it an indispensable asset for researchers striving to unravel the complexities of SARS-CoV-2 and combat the ongoing global health crisis.
In summary, the Recombinant SARS-CoV-2 Spike RBD(Q409E)(His Tag) stands as a pinnacle of scientific innovation, offering an unparalleled opportunity to explore the intricate dynamics of viral-host interactions. This product is poised to revolutionize the field of virology, empowering researchers to make significant strides towards understanding, combating, and ultimately eradicating the SARS-CoV-2 virus.
Share
